References
Barry, V. C., Belton, J. G., O'Sullivan, J. F., and Twomey, D., J. Chem. Soc., 896 (1956).
Barry, V. C., Conalty, M. L., and Gaffney, E. E., J. Pharm. and Pharmacol., 8, 1089 (1956).
Barry, V. C., Belton, J. G., O'Sullivan, J. F., and Twomey, D., J. Chem. Soc., 3347 (1956).
Kehrmann, F., and Cordone, M., Berichte, 46, 3009 (1913).
Conalty, M. L., Irish J. Med. Sci., 475 (1954).
Knox, R., Swait, E., and Woodroffe, R., J. Gen. Microbiol., 15, 359 (1956).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
BARRY, V., BELTON, J., CONALTY, M. et al. A New Series of Phenazines (Rimino-Compounds) With High Antituberculosis Activity. Nature 179, 1013–1015 (1957). https://doi.org/10.1038/1791013a0
Issue Date:
DOI: https://doi.org/10.1038/1791013a0
- Springer Nature Limited
This article is cited by
-
Clofazimine broadly inhibits coronaviruses including SARS-CoV-2
Nature (2021)
-
2-aminoimidazoles collapse mycobacterial proton motive force and block the electron transport chain
Scientific Reports (2019)
-
Development of an Innovative Quality by Design (QbD) Based Stability-Indicating HPLC Method and its Validation for Clofazimine from its Bulk and Pharmaceutical Dosage Forms
Chromatographia (2019)
-
New antituberculous drugs derived from natural products: current perspectives and issues in antituberculous drug development
The Journal of Antibiotics (2018)
-
Varying effects of common tuberculosis drugs on enhancing clofazimine activity in vitro
Emerging Microbes & Infections (2017)